TY  - JOUR
T1  - Rational Approach to Pharmacotherapy in Respiratory Diseases during the COVID-19 Pandemic
A1  - Lutsak Iryna
A1  - Litvinenko Dmytro
A1  - Meleha Kseniia
A1  - Barabanchyk Olena
A1  - Savchuk Alina
A1  - Maltsev Dmytro
JF  - Journal of Medical Sciences and Interdisciplinary Research
JO  - J Med Sci Interdiscip Res
SN  - 3108-4826
Y1  - 2022
VL  - 2
IS  - 1
DO  - 10.51847/paRajRCk5I
SP  - 9
EP  - 14
N2  - This article aims to highlight the treatment of respiratory diseases during the COVID-19 pandemic, with a focus on vaccination and the impact of the disease on children. The study uses a longitudinal design, referencing English-language resources such as UpToDate, peer-reviewed journals, and surveys from outpatient healthcare practitioners. While there were no major changes to the treatment of respiratory diseases during the pandemic, there were updates to the recommendations for aerosolized drug delivery. It was recommended that the use of targeted therapies and antileukotriene medications for patients with bronchial asthma and confirmed COVID-19 be delayed until recovery. COVID-19 has also changed the doctor-patient relationship, leading to an increase in telemedicine. This pandemic highlights the importance of vaccination and population immunity, which is now achievable. In addition, the treatment of other conditions must continue to be considered, with treatment decisions made in light of the ongoing pandemic.
UR  - https://smerpub.com/article/rational-approach-to-pharmacotherapy-in-respiratory-diseases-during-the-covid-19-pandemic-yei5mz3oxndkzwo
ER  -